Plotkin SA - Search Results

1

The Status of Vaccine Development Against the Human Cytomegalovirus.

Plotkin SA, Wang D, Oualim A, Diamond DJ, Kotton CN, Mossman S, Carfi A, Anderson D, Dormitzer PR. Plotkin SA, et al. J Infect Dis. 2020 Mar 5;221(Suppl 1):S113-S122. doi: 10.1093/infdis/jiz447. J Infect Dis. 2020. PMID: 32134478 Free PMC article. Review.

2

The status of cytomegalovirus vaccine.

Starr SE, Friedman HM, Plotkin SA. Starr SE, et al. Among authors: plotkin sa. Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S964-5. doi: 10.1093/clind/13.supplement_11.s964. Rev Infect Dis. 1991. PMID: 1664136 Review.

3

Vaccines for the prevention of human cytomegalovirus infection.

Plotkin SA, Starr SE, Friedman HM, Gonczol E, Brayman K. Plotkin SA, et al. Rev Infect Dis. 1990 Sep-Oct;12 Suppl 7:S827-38. doi: 10.1093/clinids/12.supplement_7.s827. Rev Infect Dis. 1990. PMID: 2173112 Review.

4

Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.

Adler SP, Starr SE, Plotkin SA, Hempfling SH, Buis J, Manning ML, Best AM. Adler SP, et al. Among authors: plotkin sa. J Infect Dis. 1995 Jan;171(1):26-32. doi: 10.1093/infdis/171.1.26. J Infect Dis. 1995. PMID: 7798679 Clinical Trial.

5

Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines.

Wang JB, Adler SP, Hempfling S, Burke RL, Duliège AM, Starr SE, Plotkin SA. Wang JB, et al. Among authors: plotkin sa. J Infect Dis. 1996 Aug;174(2):387-92. doi: 10.1093/infdis/174.2.387. J Infect Dis. 1996. PMID: 8699071

6

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.

Clark HF, Offit PA, Ellis RW, Eiden JJ, Krah D, Shaw AR, Pichichero M, Treanor JJ, Borian FE, Bell LM, Plotkin SA. Clark HF, et al. Among authors: plotkin sa. J Infect Dis. 1996 Sep;174 Suppl 1:S73-80. doi: 10.1093/infdis/174.supplement_1.s73. J Infect Dis. 1996. PMID: 8752294 Review.

7

Vaccination against cytomegalovirus.

Plotkin SA. Plotkin SA. Arch Virol Suppl. 2001;(17):121-34. doi: 10.1007/978-3-7091-6259-0_13. Arch Virol Suppl. 2001. PMID: 11339541 Review.

8

Development of a cytomegalovirus vaccine: lessons from recent clinical trials.

Gonczol E, Plotkin S. Gonczol E, et al. Expert Opin Biol Ther. 2001 May;1(3):401-12. doi: 10.1517/14712598.1.3.401. Expert Opin Biol Ther. 2001. PMID: 11727514 Review.

9

Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee.

Arvin AM, Fast P, Myers M, Plotkin S, Rabinovich R; National Vaccine Advisory Committee. Arvin AM, et al. Clin Infect Dis. 2004 Jul 15;39(2):233-9. doi: 10.1086/421999. Epub 2004 Jun 25. Clin Infect Dis. 2004. PMID: 15307033 Review.

10

Correcting a public health fiasco: The need for a new vaccine against Lyme disease.

Plotkin SA. Plotkin SA. Clin Infect Dis. 2011 Feb;52 Suppl 3:s271-5. doi: 10.1093/cid/ciq119. Clin Infect Dis. 2011. PMID: 21217175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

564 results

Search Page